Growth Metrics

Galectin Therapeutics (GALT) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Galectin Therapeutics 165.77 Mn 151.67 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 38.46%
Sep 30, 2025 -8.33%
Jun 30, 2025 20.00%
Mar 31, 2025 21.05%
Dec 31, 2024 -5.56%
Sep 30, 2024 10.00%
Jun 30, 2024 -5.26%
Mar 31, 2024 -18.75%
Dec 31, 2023 33.33%
Sep 30, 2023 -60.00%
Jun 30, 2023 21.05%
Mar 31, 2023 -5.56%
Dec 31, 2022 -28.57%
Sep 30, 2022 12.50%
Jun 30, 2022 5.88%
Mar 31, 2022 -41.67%
Dec 31, 2021 14.29%
Sep 30, 2021 6.67%
Jun 30, 2021 -36.36%
Mar 31, 2021 15.38%
Dec 31, 2020 -30.00%
Sep 30, 2020 9.09%
Jun 30, 2020 -83.33%
Mar 31, 2020 50.00%
Dec 31, 2019 -140.00%
Sep 30, 2019 16.67%
Jun 30, 2019 70.00%
Mar 31, 2019 70.59%
Dec 31, 2018 -1,071.43%
Sep 30, 2018 -36.36%
Jun 30, 2018 -8.33%
Mar 31, 2018 271.43%
Dec 31, 2017 46.15%
Sep 30, 2017 7.14%
Jun 30, 2017 6.67%
Mar 31, 2017 6.25%
Dec 31, 2016 0.00%
Sep 30, 2016 20.00%
Jun 30, 2016 16.67%
Mar 31, 2016 -26.32%
Dec 31, 2015 26.92%
Sep 30, 2015 -23.81%
Jun 30, 2015 4.55%
Mar 31, 2015 -29.41%
Dec 31, 2014 0.00%
Sep 30, 2014 0.00%
Jun 30, 2014 37.04%
Mar 31, 2014 -92.86%
Dec 31, 2013 36.36%
Sep 30, 2013 69.44%
Jun 30, 2013 -227.27%
Mar 31, 2013 -29.41%
Dec 31, 2012 10.53%
Sep 30, 2012 0.00%
Jun 30, 2012 -11.76%
Mar 31, 2012 41.38%
Dec 31, 2011 -52.63%
Sep 30, 2011 44.12%
Jun 30, 2011 -41.67%
Mar 31, 2011 70.00%
Dec 31, 2010 -2,566.67%
Sep 30, 2010 40.00%